Member of Lyonbiopole
NETRIS Pharma is a clinical stage immune-oncology company developing therapeutic molecules for targeted therapy of cancer, based on the innovative concept of dependence receptors. The lead asset is a anti-netrin-1 blocking antibody that is currently assessed in various phase 2 clinical trials.
Strategic application domain: Human Medicine
Application market: Oncology
Type of activity: Therapeutics, Pharma or Biotech
Technologies: Antibodies - Protein - Peptide
Created on june 26th, 2008 - 13 employees
Address
Centre Léon Bérard
28 rue Laennec 69008 LYON
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.